A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States
Source : https://link.springer.com/article/10.1007/s12325-021-01781-z
Introduction Migraine is associated with considerable disability for patients not adequately managed with current standards of care. New acute therapies may offer relief for this population of patients; however, population size and associated potential costs of new therapies are unclear. In this study, a conceptual framework was developed to estimate anticipated use of new acute therapies.
-
Huma Sheikh, CEO, NY Neurology Medicine, PCJune 18, 2021This is a good practical review.